{"@id":"https://bioecon.ru/technology/translational-pharmaceutics/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/translational-pharmaceutics/","json":"https://cn.bioecon.ru/api/v1/technology/translational-pharmaceutics/index.json"},"id":"translational-pharmaceutics","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/recursion-pharmaceuticals/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/biohaven/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/imperagen/","https://bioecon.ru/companies/iontech-2000-jsc/","https://bioecon.ru/companies/formulaciones-quimicas-sa/","https://bioecon.ru/companies/mgi/"]},"maturity":8,"name":"整合配方优化、快速GMP生产与实时临床验证的转化药剂学技术","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"伴随式小批量GMP临床制剂快速生产"},{"n":2,"title":"自适应临床试验方案快速给药"},{"n":3,"title":"基于真实人体PK反馈的两周极速迭代"},{"n":4,"title":"锁定终版处方消除II期临床开发风险"}],"summary":"一种将临床前制剂处方优化、实时小批量GMP药品生产与健康志愿者I期临床药代评估融为一体的闭环平台，大幅压缩药物开发周期与临床转化风险。","url":"/technology/translational-pharmaceutics/","verified":"2026-11-22"}